Home › Funds › Pacer Advisors, Inc. › GILD
Pacer Advisors, Inc. position in GILD
GILEAD SCIENCES INC · Health Care
Pacer Advisors, Inc. reported holding 3,110,000 shares of GILD (GILEAD SCIENCES INC) in its Q2 2026 13F filing — a position valued at US$392.9M, representing 1.12% of its reported portfolio and ranking #11 among its reported holdings. Pacer Advisors, Inc. has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Pacer Advisors, Inc.'s GILD position evolved
Pacer Advisors, Inc. first disclosed a stake in GILD in Q3 2023 at 4,552,732 shares (US$341.2M). The position peaked in Q4 2024 at 6,434,665 shares, worth US$594.4M. Across 12 filings, Pacer Advisors, Inc. increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 3,110,000 shares valued at US$392.9M — an increase of 164,758 shares quarter over quarter.. Notable position changes include a 25% increase in Q1 2024 (shares fell 6% over the following quarter), a 90% trim in Q3 2024 (shares rose 11% over the following quarter), a 723% increase in Q4 2024 (shares rose 21% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.55M | $341.18M | New |
| Q4 2023 | 5.05M | $408.83M | Add |
| Q1 2024 | 6.32M | $463.30M | Add |
| Q2 2024 | 7.89M | $541.31M | Add |
| Q3 2024 | 781.59K | $65.53M | Reduce |
| Q4 2024 | 6.43M | $594.37M | Add |
| Q1 2025 | 4.89M | $547.38M | Reduce |
| Q2 2025 | 4.12M | $456.75M | Reduce |
| Q3 2025 | 3.59M | $398.57M | Reduce |
| Q4 2025 | 3.38M | $415.08M | Reduce |
| Q1 2026 | 2.95M | $410.48M | Reduce |
| Q2 2026 | 3.11M | $392.92M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GILD and 13F data
GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GILD
- Fidelity Management & Research (FMR) 66.87M sh · $8.45B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Invesco Ltd 39.82M sh · $5.03B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 30.00M sh · $3.79B · Q2 2026
- Dodge & Cox 23.68M sh · $2.99B · Q2 2026
- DODGE & COX 23.68M sh · $2.99B · Q2 2026
More on Pacer Advisors, Inc.
FAQ
How long has Pacer Advisors, Inc. held GILD?
Pacer Advisors, Inc. has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Pacer Advisors, Inc.'s current position in GILD?
As of Q2 2026, Pacer Advisors, Inc. holds 3.11M shares of GILD (GILEAD SCIENCES INC), valued at $392.92M, representing 1.12% of its reported portfolio and ranking #11.
Has Pacer Advisors, Inc. been buying or selling GILD?
In the latest 13F filing (Q2 2026), Pacer Advisors, Inc. increased its position in GILD. The position peaked in Q4 2024 at 6.43M shares.
Which other funds hold GILD?
Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.